SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS

Clinical trials for SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS trials appear

Sign up with your email to follow new studies for SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo targets tough brain cancers in early trial

Disease control UNKNOWN_STATUS

This early-phase study tests an experimental oral drug called CTO, alone or combined with standard treatments, in 100 adults with advanced solid tumors or aggressive brain cancers (glioblastoma). The main goal is to find the safest dose and understand side effects. Researchers wi…

Matched conditions: SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS

Phase: PHASE1 • Sponsor: Tactical Therapeutics, Inc. • Aim: Disease control

Last updated May 07, 2026 18:41 UTC

SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS

Get alerted when new SOLID TUMORS, GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMAS trials appear

New drug combo targets tough brain cancers in early trial